These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 25850019)
81. Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. I. Study design and results of the first year of observation. Mosley WH; McCormack WM; Fahimuddin M; Aziz KM; Rahman AS; Chowdhury AK; Martin AR; Feeley JC; Phillips RA Bull World Health Organ; 1969; 40(2):177-85. PubMed ID: 5306538 [TBL] [Abstract][Full Text] [Related]
82. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate. Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477 [TBL] [Abstract][Full Text] [Related]
83. Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India. Kar SK; Pach A; Sah B; Kerketta AS; Patnaik B; Mogasale V; Kim YH; Rath SB; Shin S; Khuntia HK; Bhattachan A; Puri MK; Wierzba TF; Kaljee LM Hum Vaccin Immunother; 2014; 10(10):2834-42. PubMed ID: 25483631 [TBL] [Abstract][Full Text] [Related]
84. A controlled field trial of the effectiveness of monovalent classical and El Tor cholera vaccines in the Philippines. Philippines Cholera Committee Bull World Health Organ; 1973; 49(1):13-9. PubMed ID: 4596491 [TBL] [Abstract][Full Text] [Related]
85. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam. Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967 [TBL] [Abstract][Full Text] [Related]
86. A controlled field trial of plain and aluminium hydroxide-adsorbed cholera vaccines in Surabaya, Indonesia, during 1973--75. Saroso JS; Bahrawi W; Witjaksono H; Budiarso RL; Brotowasisto ; Bencić Z; Dewitt WE; Gomez CZ Bull World Health Organ; 1978; 56(4):619-27. PubMed ID: 365388 [TBL] [Abstract][Full Text] [Related]
87. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Ali M; Emch M; von Seidlein L; Yunus M; Sack DA; Rao M; Holmgren J; Clemens JD Lancet; 2005 Jul 2-8; 366(9479):44-9. PubMed ID: 15993232 [TBL] [Abstract][Full Text] [Related]
88. Preventing cholera in India: Synthesizing evidences through a systematic review for policy discussion on the use of oral cholera vaccine. Panda S; Chatterjee P; Deb A; Kanungo S; Dutta S Vaccine; 2020 Feb; 38 Suppl 1():A148-A156. PubMed ID: 31405636 [TBL] [Abstract][Full Text] [Related]
89. The case for reactive mass oral cholera vaccinations. Reyburn R; Deen JL; Grais RF; Bhattacharya SK; Sur D; Lopez AL; Jiddawi MS; Clemens JD; von Seidlein L PLoS Negl Trop Dis; 2011 Jan; 5(1):e952. PubMed ID: 21283614 [TBL] [Abstract][Full Text] [Related]
90. Effectiveness of the Euvichol® oral cholera vaccine at 2 years: A case-control and bias-indicator study in Haiti. Matias WR; Guillaume Y; Cene Augustin G; Vissieres K; Ternier R; Slater DM; Harris JB; Franke MF; Ivers LC Int J Infect Dis; 2024 Feb; 139():153-158. PubMed ID: 38000510 [TBL] [Abstract][Full Text] [Related]
91. Pregnancy Outcomes after a Mass Vaccination Campaign with an Oral Cholera Vaccine in Guinea: A Retrospective Cohort Study. Grout L; Martinez-Pino I; Ciglenecki I; Keita S; Diallo AA; Traore B; Delamou D; Toure O; Nicholas S; Rusch B; Staderini N; Serafini M; Grais RF; Luquero FJ PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004274. PubMed ID: 26713614 [TBL] [Abstract][Full Text] [Related]
92. Adverse events after oral vaccination against cholera with CVD103-HgR. Wiedermann G; Kollaritsch H; Jeschko E; Kundi M; Herzog C; Wegmüller B Wien Klin Wochenschr; 1998 May; 110(10):376-8. PubMed ID: 9654693 [TBL] [Abstract][Full Text] [Related]
93. Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS. López-Gigosos R; García-Fortea P; Reina-Doña E; Plaza-Martín E Travel Med Infect Dis; 2007 Nov; 5(6):380-4. PubMed ID: 17983977 [TBL] [Abstract][Full Text] [Related]
94. Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016. Ferreras E; Matapo B; Chizema-Kawesha E; Chewe O; Mzyece H; Blake A; Moonde L; Zulu G; Poncin M; Sinyange N; Kasese-Chanda N; Phiri C; Malama K; Mukonka V; Cohuet S; Uzzeni F; Ciglenecki I; Danovaro-Holliday MC; Luquero FJ; Pezzoli L PLoS One; 2019; 14(8):e0219040. PubMed ID: 31469853 [TBL] [Abstract][Full Text] [Related]
95. Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission. Ali M; Emch M; Yunus M; Sack D; Lopez AL; Holmgren J; Clemens J Pediatr Infect Dis J; 2008 Jan; 27(1):33-7. PubMed ID: 18162935 [TBL] [Abstract][Full Text] [Related]
96. The history of OCV in India and barriers remaining to programmatic introduction. Mogasale V; Kanungo S; Pati S; Lynch J; Dutta S Vaccine; 2020 Feb; 38 Suppl 1():A41-A45. PubMed ID: 31982258 [TBL] [Abstract][Full Text] [Related]
97. Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam. Thiem VD; Deen JL; von Seidlein L; Canh DG; Anh DD; Park JK; Ali M; Danovaro-Holliday MC; Son ND; Hoa NT; Holmgren J; Clemens JD Vaccine; 2006 May; 24(20):4297-303. PubMed ID: 16580760 [TBL] [Abstract][Full Text] [Related]
98. Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda. Bwire G; Roskosky M; Ballard A; Brooks WA; Okello A; Rafael F; Ampeire I; Orach CG; Sack DA BMJ Open; 2020 Dec; 10(12):e038464. PubMed ID: 33303438 [TBL] [Abstract][Full Text] [Related]
99. Epidemiology and transmission of V. cholerae O1 and V. cholerae O139 infections in Delhi in 1993. Singh J; Bora D; Khanna KK; Jain DC; Sachdeva V; Sharma RS; Verghese T J Diarrhoeal Dis Res; 1996 Sep; 14(3):182-6. PubMed ID: 9019011 [TBL] [Abstract][Full Text] [Related]
100. Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh. Khan AI; Islam MS; Islam MT; Ahmed A; Chowdhury MI; Chowdhury F; Siddik MAU; Clemens JD; Qadri F Vaccine; 2019 Feb; 37(6):827-832. PubMed ID: 30639459 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]